Figure 3

DM and PM patients demonstrate a correlation between modified MITAX score and type 1 IFN gene composite score in the blood. (a) Comparisons between modified MITAX score and the type 1 IFN-inducible gene composite score over time for seven patients (BGE15, BGE92, BGE99, BGE10, BGE106, BGE119 and BGE147) with at least four total visits. (b) An additional correlation is seen for a PM patient, BGE92 between the type 1 IFN-inducible gene composite score and creatine kinase levels across time. Even though the disease activity of the patient increased substantially, the muscle disease MITAX subscore was already at a maximal value (9 points).